MedPath

TEAMcare for Diabetes in Mental Health Centers

Not Applicable
Completed
Conditions
Diabetes
Interventions
Other: TEAMcare treatment of diabetes
Registration Number
NCT02011529
Lead Sponsor
University of Washington
Brief Summary

This proposal aims to demonstrate the feasibility and acceptability of adapting TEAMcare for patients with schizophrenia. The aim of this innovative mental health center-based team intervention is to improve diabetes, cardiovascular and psychiatric outcomes among patients with poorly controlled type 2 diabetes. The study will be conducted in two phases over the 2-year grant period.

Phase 1. Development of the adapted TEAMcare intervention and training of team members.

Phase 2. During year 2, we will implement the intervention on the caseload of 40 outpatients at Harborview Mental Health Services with schizophrenia and poorly controlled type 2 diabetes. The intervention involves the management of subjects' diabetes, hypertension, and hyperlipidemia by a CMHC diabetes team for 6 months (advanced nurse specialist on-site at supervised in weekly meetings by a psychiatrist and a UW Diabetes Center endocrinologist).

The primary aim of this pilot research grant is to evaluate the feasibility of implementing this complex intervention, in order to guide the design of a larger scale efficacy study (R01). Both process and outcome measures will be evaluated at baseline, and at 3- and 6-month follow-up visits for the 40 subjects enrolled in this feasibility trial.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
35
Inclusion Criteria
  • adult (18-70 years);
  • enrolled to receive mental health treatment at Harborview Mental Health Services or Downtown Emergency Services Mental Health center
  • a diagnosis of type 2 diabetes mellitus or cardiovascular disease
  • Hemoglobin A1c >8 or BP > 140/90
Exclusion Criteria
  • cognitive, hearing, or language impairment that would preclude a subject from providing informed consent;
  • current suicidality, homicidality, or grave disability that requires psychiatric hospitalization;
  • current substance abuse or dependence, as defined by SCID.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TEAMcare treatment of diabetesTEAMcare treatment of diabetes-
Primary Outcome Measures
NameTimeMethod
Hemoglobin A1c6 months
Secondary Outcome Measures
NameTimeMethod
LDL cholesterol6 months
Blood Pressure6 months

Trial Locations

Locations (1)

Harborview Medical Center

🇺🇸

Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath